Jabbardarjani Hamid Reza, Radpey Badiozaman, Kharabian Shahram, Masjedi Mohammad Reza
Tracheal Disease Research Center, NRITLD, Massih Daneshvari Hospital, Shahid Beheshti University, M.C., Tehran, Iran.
Lung. 2008 Sep-Oct;186(5):293-7. doi: 10.1007/s00408-008-9088-4. Epub 2008 May 8.
Tracheobronchopathia osteochondroplastica (TO) is a rare benign disease of the endobronchial system with nonspecific symptoms and different treatment approaches. We report on a group of patients with TO and discuss their presentation and their treatment modalities. Between 2000 and 2006, the medical records of patients with TO were studied at the Interventional Pulmonary Unit of the Tracheal Disease Research Center at Masih Daneshvary Hospital, a referral center for respiratory diseases in Tehran, Iran. We analyzed and studied patients' demographics, symptom presentation, radiographic appearance, bronchoscopic findings, and their subsequent treatment. Of the 8,760 patients who underwent flexible bronchoscopy (FOB) at our center over 6 years, 10 were diagnosed with TO; their median age was 51 years (range = 16-68 years) and 6 were men. Computerized tomography (CT) revealed mucosal irregularity and calcified nodules. Histopathologic examination of tissue biopsy through bronchoscopy was used for definitive diagnosis of TO. Bronchoscopy findings showed the endobronchial lesions to be firm and glossy. Cartilaginous nodules were present in central airways. Treatment included endobronchial Nd:YAG laser photoevaporation (LPE) (n = 10), coring of the lesions with the tip of the rigid bronchoscope (n = 4), and endobronchial stent placement (n = 1). Symptoms were considerably relieved in six cases but there was no significant improvement noted in three patients. One patient died after 6 years of treatment and follow-up. TO is a rare disease and the diagnosis should be suspected based on CT findings or bronchoscopic examination of the airways. Histopathologic examination is required for confirmation of diagnosis. Treatment is palliative and it includes LPE, coring through a rigid bronchoscope, and endobronchial stent placement.
气管支气管骨软骨化生(TO)是一种支气管内系统的罕见良性疾病,症状不具特异性,治疗方法多样。我们报告一组TO患者,并讨论其临床表现及治疗方式。2000年至2006年间,在伊朗德黑兰呼吸系统疾病转诊中心马西赫·达内什瓦里医院气管疾病研究中心的介入肺科,对TO患者的病历进行了研究。我们分析并研究了患者的人口统计学特征、症状表现、影像学表现、支气管镜检查结果及其后续治疗情况。在我们中心6年间接受柔性支气管镜检查(FOB)的8760例患者中,10例被诊断为TO;他们的中位年龄为51岁(范围 = 16 - 68岁),男性6例。计算机断层扫描(CT)显示黏膜不规则及钙化结节。通过支气管镜进行组织活检的组织病理学检查用于TO的确诊。支气管镜检查结果显示支气管内病变质地硬且有光泽。中央气道存在软骨结节。治疗方法包括支气管内钕钇铝石榴石激光光凝术(LPE)(n = 10)、用硬支气管镜尖端切除病变组织(n = 4)以及支气管内支架置入(n = 1)。6例患者症状明显缓解,但3例患者无显著改善。1例患者在治疗及随访6年后死亡。TO是一种罕见疾病,基于CT表现或气道支气管镜检查应怀疑该病。确诊需要组织病理学检查。治疗是姑息性的,包括LPE、通过硬支气管镜切除病变组织以及支气管内支架置入。